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ABSTRACT
Myelolipoma (ML) is an uncommon benign mesenchymal neoplasia composed of mature adipose and hematopoietic 
tissues of uncertain etiology. Less than 3% of MLs occur in the mediastinal topography. The main differential diagnosis 
involves extramedullary hematopoiesis; therefore, pathological evaluation is essential for the definitive diagnosis. The 
authors report the case of a 50-year-old man diagnosed with congenital dyserythropoiesis and secondary hemosiderosis, 
who presented a posterior mediastinal tumor. The tumor was resected. It was macroscopically characterized by mature fat 
tissue with fibrous areas and soft consistency, which was yellowish at the cut surface. Histology revealed a well-defined 
nodule composed of adipocytes and hematopoietic tissue represented by erythroid, granulocytic, and megakaryocytic 
series, which was consistent with the diagnosis of ML located in the posterior mediastinum. There was no recurrence of 
the lesion during the 3-year follow-up. The aim of this report is to show the diagnosis of an unusual mediastinal lesion 
in the context of a chronic hematologic disease. 
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INTRODUCTION
Myelolipoma (ML) is a benign mesenchymal 
neoplasm composed of hematopoietic and mature 
adipose tissue.1 The incidence of this tumor is estimated 
in up to 0.2% of mesenchymal tumors, and it can 
occur in various parts of the body, but predominantly 
in the adrenals. The extra-adrenal location is unusual 
(15%) and includes the retroperitoneum, pelvis, pre-
sacral region, stomach, and liver. In the lungs and 
mediastinum, the occurrence of ML is quite infrequent 
accounting for 3% of all cases.1,2 This report shows an 
rare case of ML located in the posterior mediastinum 
in a patient with congenital dyserythropoiesis.
CASE REPORT
A 50-year-old Caucasian male patient, previously 
diagnosed with congenital dyserythropoiesis, secondary 
hemosiderosis, and systemic arterial hypertension, 
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presented a nodule in the right posterior mediastinum. 
Despite the diagnosis of chronic anemia, the patient 
was asymptomatic and was in steady control of the 
hemoglobin and the hematocrit levels. In a routine 
thoracic and abdominal computed tomography (CT), a 
nodule with soft tissue density, which measured 3.5 cm 
in diameter, was detected with enhancement after 
intravenous contrast injection localized in the right 
posterior mediastinum, in paravertebral topography 
(Figure 1).
The patient was a former smoker and underwent a 
splenectomy and a liver biopsy 5 years ago. The spleen 
was congested and weighed 1280 g (reference value 
150 g). Histologic review of the spleen and liver slides 
revealed splenic congestion, and hemosiderin deposits 
in both the spleen and the liver (Figure 2A to 2D). 
Immunohistochemistry failed to show myeloid 
metaplasia in the splenic samples. The patient did not 
have a bone marrow biopsy.
In this clinical and radiological context, the 
video-assisted thoracic lesion resection was indicated 
considering the diagnostic hypothesis of paraganglioma, 
schwannoma, and nodal hematopoietic tumor 
infiltration. The gross examination of the surgical 
specimen revealed an oval-shaped tumor mass with 
a lobular surface, covered by a thin membrane, with 
soft consistency measuring 5.6 × 3.7 × 1.9 cm and 
weighting 10 g (Figure 3A). Histopathology revealed a 
well-defined nodular lesion (Figure 3B) predominantly 
consisting of adipose tissue, intermingled with 
hematopoietic tissue, which was represented by an 
erythroid, granulocytic, and megakaryocytic series.
Immunohistochemistry positivity for glycophorin 
A, myeloperoxidase, and Factor VIII confirmed the 
presence of erythroid cells, granulocytic lineage, 
and megakaryocytes, respectively, in the surgical 
specimen, which was consistent with the diagnosis 
of ML (Figure 4A-C). The patient was followed-up for 
3 years without relapses; however, he was submitted 
to monthly bloodletting.
DISCUSSION
MLs are benign and nonfunctioning tumors 
composed of mixed hematopoietic and mature adipose 
tissue, in varying proportions, which are usually located 
in the adrenal glands.3,4 Since the first descriptions in 
the early 20th century,1 other topographies have been 
reported in (i) the soft tissue; (ii) the retroperitoneum; 
(iii) the spleen; (iv) the liver; (v) the stomach; and 
(vi) the nasal cavity.4 The extra-adrenal MLs occur in 
up to 15% of cases.5,6 The lungs and mediastinum 
are unusual sites for such occurrences. In a literature 
review, Xu et al.5 reported 10 cases of intrapulmonary 
ML: 8 had isolated lesions, and 2 had a multifocal 
clinical presentation. The mediastinum is the site of 
occurrence in approximately 3.0% of cases.4
In a recent study, Xiong et al.3 described the 
clinical and pathological aspects of 28 cases of 
mediastinal MLs.3 In this series, the symptoms, when 
present, were nonspecific and were represented 
by changes in the respiratory system (10%), such 
as dyspnea, hematopoietic abnormalities (9%), 
endocrine disorders (6%), and cardiovascular disorders 
(5%). Most cases (93%) occurred in the posterior 
mediastinum as a single lesion. The mean age of these 
28 patients with mediastinal MLs was 64 years, with 
a slight male predominance. The series reported by 
Shen et al.2, which comprised 16 patients with thoracic 
ML, showed singular chest lesions in 13 cases.2 Patients 
with extra-adrenal MLs were older than those with 
adrenal lesions.6
The diagnosis of ML is often made incidentally by 
imaging studies, such as CT and magnetic resonance, 
due to the scarcity of typical symptoms. Similarly, 
imaging findings are also nonspecific.4 The reported 
tumoral mass of our patient was described as a nodular 
Figure 1. Thoracic axial computed tomography showing 
a paravertebral nodular lesion in the right posterior 
mediastinum with soft tissue density (arrow).
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lesion with soft tissue density, which showed some 
high-intensity regions with attenuation enhancement 
after intravenous contrast injection. This nonspecific 
imaging pattern of presentation supports the 
differential diagnosis of bronchial malignancies, 
lymphoproliferative disorders, neurogenic tumors, and 
lipomatous and metastatic lesions.1,4 In this setting, 
the gold standard examination for the diagnosis of 
ML is the histological examination.1,4 Macroscopically, 
generally, the ML are well-defined tumors that are often 
enclosed by a thin capsule measuring approximately 
4-5 cm in diameter.2 The cut surface can be variegated, 
depending on the ratio between fat and hematopoietic 
tissues. In our patient, the lesion surface had a pale 
yellowish aspect due to the increased adipose tissue 
component. The histological examination showed the 
varied proportion of hematopoietic tissue intermingled 
with adult adipose tissue. The hematopoietic 
component was recognized by the presence of 
erythroid, granulocytic, and megakaryocytic series. 
In our patient, there were no bone spurs or hyperplasia 
of any hematopoietic component, and the adipose 
component did not present atypia.2,4
The pathogeny of ML is unknown. Shen et al.2 and 
Xiong et al.3 compiled some possible explanations for 
Figure 2. A and B - Photomicrography of the spleen; A - Splenic congestion, hypoplastic white pulp, and an 
absence of myeloid metaplasia (H&E, 200X); B - Hemosiderosis: hemosiderin deposits stained in blue (Perls, 400X); 
C and D - Photomicrography of the liver; C - Hepatocellular ballooning, and hemosiderin deposits (H&E, 400X); D - 
Hemosiderosis: hemosiderin deposits stained blue (Perls, 400X).
Figure 3. A - Gross appearance of the oval shaped and 
lobular mediastinal tumor; B - Photomicrography of 
the myelolipoma: a panoramic view of the histological 
section of the specimen showing a circumscribed nodular 
area primarily consisting of adipose tissue (H&E, low 
magnification view).
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the genesis of ML: (i) it could be derived from bone 
marrow emboli that may lodge in different regions of 
the organism; (ii) it could be derived from embryonic 
primitive mesenchymal cells; (iii) it could be derived 
from the metaplastic transformation of embryonic 
stromal cells after chromosomal translocation, similar 
to that observed in myelogenous leukemia; and 
iv) some disorders, such as the endocrine diseases 
like Cushing’s syndrome, diabetes mellitus, Addison’s 
disease, Cohn’s syndrome, pheochromocytoma, 
obesity, and even hypertension that accompany ML 
may play a role in the genesis of this neoplasm.2,3, 
Fonda et al.7 proposed that ML may derived from 
projection of hematopoietic tissue (including stem 
cells) by bone microfractures. Some authors emphasize 
that the development of ML may be associated with 
prolonged and excessive steroid production or genome 
defects of the endocrine glands responsible for multiple 
endocrine neoplasia type 1.7,8
In general, patients with ML do not present with 
hematopoietic disorders. The presence of anemia 
or blood disorders does not exclude the diagnosis. 
The patient in this report presented the diagnosis of 
congenital dyserythropoiesis with hemosiderosis due 
to repeated blood transfusions, having undergone 
a splenectomy. Congenital dyserythropoiesis is a 
rare, inherited anemia that leads to the failure of 
erythroid maturation accompanied by hemosiderosis 
and extramedullary hematopoiesis.9 In this patient’s 
case, it is possible that the persistent erythropoietin 
stimulation, due to chronic anemia, may have played an 
important role in tumor development. It is interesting 
to note that extramedullary hematopoiesis occurs as 
mediastinal and paravertebral masses.
In  th i s  c l in i co-patho log ica l  context ,  an 
important differential diagnosis is extramedullary 
erythropoiesis. This is a commonly multifocal lesion 
that, when presented in the chest, develops in the 
perivertebral and mediastinal topography.9 It is 
histologically characterized by an irregular shape, with 
a predominance of hematopoietic elements, especially 
erythroid and myeloid series; however there also may 
be hyperplasia of erythroid series.6,10 In contrast, our 
patient had chronic anemia due to the underlying 
blood disease and had a well-defined singular nodular 
lesion discovered incidentally on routine imaging. 
Additionally, the microscopy showed an abundant 
adipose component and all the hematopoietic series 
without atypia. These aspects were consistent with 
the diagnosis of ML.
The most adopted therapeutic approach is to 
remove the lesion by conventional thoracotomy or a 
video-assisted method, depending on the size of the 
lesion. The prognosis is usually excellent.1-3
Figure 4. Photomicrography of the surgical specimen. 
A - Glycophorin positivity in the erythroid series colonies 
(Immunohistochemistry, 400X); B - Granulocytic 
lineage confirmed by positivity for myeloperoxidase 
(Immunohistochemistry, 400X); C - Megakaryocytes highlighted 
by the positivity for Factor VIII (Immunohistochemistry, 
200X).
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CONCLUSION
This report presents the case of a patient 
with congenital dyserythropoiesis, with secondary 
hemosiderosis, whose tomographic fol low-up 
examination revealed the presence of a tumor in the 
posterior mediastinum. The tumor was removed, and 
the pathology confirmed the diagnosis of ML—a rare 
tumor that was found in an unusual topography.
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